Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Xenetic Biosciences Operating Margin 2013-2025 | XBIO

Current and historical operating margin for Xenetic Biosciences (XBIO) over the last 10 years. The current operating profit margin for Xenetic Biosciences as of March 31, 2025 is -142.10%.
  
Xenetic Biosciences Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $0.00B $0.00B -75.00%
2024-12-31 $0.00B $0.00B -75.00%
2024-09-30 $0.00B $0.00B -75.00%
2024-06-30 $0.00B $0.00B -100.00%
2024-03-31 $0.00B $0.00B -100.00%
2023-12-31 $0.00B $0.00B -100.00%
2023-09-30 $0.00B $-0.01B -166.67%
2023-06-30 $0.00B $-0.01B -250.00%
2023-03-31 $0.00B $-0.01B -700.00%
2022-12-31 $0.00B $-0.01B 0.00%
2022-09-30 $0.00B $-0.01B 0.00%
2022-06-30 $0.00B $-0.01B 0.00%
2022-03-31 $0.00B $-0.01B 0.00%
2021-12-31 $0.00B $-0.01B 0.00%
2021-09-30 $0.00B $0.00B 0.00%
2021-06-30 $0.00B $-0.01B 0.00%
2021-03-31 $0.00B $-0.01B 0.00%
2020-12-31 $0.00B $-0.01B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.006B $0.003B
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications. Additionally, Xenetic is leveraging PolyXen(TM), its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. PolyXen(TM) has demonstrated its ability to improve the half-life and other pharmacological properties of next-generation biologic drugs. The Company has an exclusive license agreement with Takeda Pharmaceuticals Co. Ltd. in the field of coagulation disorders and expects to earn royalty payments under this agreement.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $77.405B 29.04
Zoetis (ZTS) United States $70.254B 26.21
Takeda Pharmaceutical (TAK) Japan $47.792B 9.51
Daiichi Sankyo, - (DSNKY) Japan $40.463B 20.74
BeOne Medicines - (ONC) Cayman Islands $26.794B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.200B 0.00
Summit Therapeutics (SMMT) United States $17.074B 0.00
Merck (MKKGY) Germany $16.905B 12.39
Shionogi (SGIOY) Japan $14.104B 14.13
United Therapeutics (UTHR) United States $13.280B 11.75
Neurocrine Biosciences (NBIX) United States $12.741B 43.64
Orion OYJ (ORINY) Finland $10.673B 28.86
IPSEN (IPSEY) France $10.359B 0.00
Stevanato Group S.p.A (STVN) Italy $7.429B 45.43
Corcept Therapeutics (CORT) United States $7.228B 58.76
Ionis Pharmaceuticals (IONS) United States $6.580B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.384B 0.00
Grifols, S.A (GRFS) Spain $6.188B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.297B 0.00
Hypermarcas (HYPMY) Brazil $3.182B 20.93
Crinetics Pharmaceuticals (CRNX) United States $2.750B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.586B 13.98
Catalyst Pharmaceuticals (CPRX) United States $2.531B 8.87
NewAmsterdam Pharma (NAMS) Netherlands $2.248B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.839B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.811B 0.00
ARS Pharmaceuticals (SPRY) United States $1.665B 0.00
Endo (NDOI) United States $1.610B 0.00
Ocular Therapeutix (OCUL) United States $1.580B 0.00
Evotec AG (EVO) Germany $1.495B 0.00
Guardian Pharmacy Services (GRDN) United States $1.326B 0.00
Harrow (HROW) United States $1.138B 0.00
ProKidney (PROK) United States $1.092B 0.00
Ardelyx (ARDX) United States $1.072B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.025B 20.51
Collegium Pharmaceutical (COLL) United States $1.014B 5.47
Verve Therapeutics (VERV) United States $0.992B 0.00
Enliven Therapeutics (ELVN) United States $0.978B 0.00
Akebia Therapeutics (AKBA) United States $0.974B 0.00
Dyne Therapeutics (DYN) United States $0.954B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.875B 0.00
Cronos Group (CRON) Canada $0.802B 0.00
Xeris Biopharma Holdings (XERS) United States $0.746B 0.00
KalVista Pharmaceuticals (KALV) United States $0.743B 0.00
Zevra Therapeutics (ZVRA) United States $0.632B 0.00
Elite Pharmaceuticals (ELTP) United States $0.626B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.622B 0.00
Relay Therapeutics (RLAY) United States $0.615B 0.00
USANA Health Sciences (USNA) United States $0.609B 13.24
Xencor (XNCR) United States $0.589B 0.00
Organogenesis (ORGO) United States $0.587B 0.00
Bioventus (BVS) United States $0.581B 14.73
Theravance Biopharma (TBPH) United States $0.561B 0.00
Oruka Therapeutics (ORKA) United States $0.501B 0.00
Siga Technologies (SIGA) United States $0.484B 10.10
Tourmaline Bio (TRML) United States $0.418B 0.00
Savara (SVRA) United States $0.392B 0.00
Altimmune (ALT) United States $0.371B 0.00
Aquestive Therapeutics (AQST) United States $0.366B 0.00
AleAnna (ANNA) United States $0.357B 0.00
Heron Therapeutics (HRTX) United States $0.336B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.329B 8.90
Nature's Sunshine Products (NATR) United States $0.291B 26.69
Nektar Therapeutics (NKTR) United States $0.282B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.262B 0.00
Aldeyra Therapeutics (ALDX) United States $0.259B 0.00
Nanobiotix S.A (NBTX) France $0.256B 0.00
OmniAb (OABI) United States $0.253B 0.00
Esperion Therapeutics (ESPR) United States $0.232B 0.00
Larimar Therapeutics (LRMR) United States $0.213B 0.00
MediWound (MDWD) Israel $0.209B 0.00
China SXT Pharmaceuticals (SXTC) China $0.205B 0.00
4D Molecular Therapeutics (FDMT) United States $0.195B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
Liminatus Pharma (LIMN) United States $0.163B 0.00
Journey Medical (DERM) United States $0.161B 0.00
Aclaris Therapeutics (ACRS) United States $0.157B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Avita Medical (RCEL) United States $0.148B 0.00
Lexeo Therapeutics (LXEO) United States $0.147B 0.00
Lyell Immunopharma (LYEL) United States $0.138B 0.00
Galectin Therapeutics (GALT) United States $0.132B 0.00
Korro Bio (KRRO) United States $0.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.122B 0.00
Champions Oncology (CSBR) United States $0.122B 20.05
Protara Therapeutics (TARA) United States $0.117B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.092B 0.00
Nutriband (NTRB) United States $0.092B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.080B 0.00
Achieve Life Sciences (ACHV) Canada $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
VAXART, INC (VXRT) United States $0.073B 0.00
Inotiv (NOTV) United States $0.073B 0.00
Metagenomi (MGX) United States $0.071B 0.00
Surrozen (SRZN) United States $0.071B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Rafael Holdings (RFL) United States $0.065B 0.00
Wellgistics Health (WGRX) United States $0.064B 0.00
Unicycive Therapeutics (UNCY) United States $0.063B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.058B 0.00
ElectroCore (ECOR) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.050B 0.00
Jupiter Neurosciences (JUNS) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 34.11
Klotho Neurosciences (KLTO) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
FibroGen (FGEN) United States $0.023B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Plus Therapeutics (PSTV) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
BioVie (BIVI) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.99
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.87
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00